Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • HIV Protease
    (5)
  • Reverse Transcriptase
    (3)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Hck
    (1)
  • NOD-like Receptor (NLR)
    (1)
  • Nucleoside Antimetabolite/Analog
    (1)
  • Src
    (1)
Filter
Search Result
Results for "

anti-retroviral

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | Inhibitors_Agonists
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
Hck-IN-1
T115381473404-51-1
Hck-IN-1 is a selective Nef-dependent Hck inhibitor (IC50s: 2.8 μM and >20 μM for Nef:Hck complex and Hck) with antiretroviral activity. Hck-IN-1 is a direct and wide HIV-1 Nef antagonist with an IC50 of 100-300 nM for wild-type HIV-1 replication.
  • $98
In Stock
Size
QTY
Stavudine
Sanilvudine, NSC 163661, d4T, BMY-27857
T14043056-17-5
Stavudine (BMY-27857), a nucleoside reverse transcriptase inhibitor analog of thymidine, has activity against HIV.
  • $33
In Stock
Size
QTY
Didanosine
ddI, 2',3'-Dideoxyinosine
T257869655-05-6
Didanosine (ddI) is a nucleoside reverse transcriptase inhibitor analog of adenosine (IC50: 0.49 μM).
  • $33
In Stock
Size
QTY
Cabotegravir
S GSK1265744, GSK744, GSK-1265744
T60981051375-10-0
Cabotegravir (S/GSK1265744) (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor and inhibits the HIV-1 integrase catalyzed strand transfer reaction (IC50: 3.0 nM).
  • $46
In Stock
Size
QTY
Lenacapavir
GS-6207
T114652189684-44-2
Lenacapavir (GS-6207) is the first HIV-1 capsid inhibitor approved by the U.S. Food and Drug Administration, the European Medicines Agency, and Health Canada for the treatment of MDR HIV-1 infection.[3]
  • $196
In Stock
Size
QTY
Dexelvucitabine
RVT, DPC-817, DFC, D-D-4FC, beta-D-D-4FC
T27154134379-77-4
Dexelvucitabine (RVT), a nucleoside reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.
  • $55
In Stock
Size
QTY